Literature DB >> 20493412

Aspirin as antiplatelet agent in diabetes. PROS-.

G Davì1, F Santilli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493412     DOI: 10.1016/j.ejim.2010.03.008

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  3 in total

1.  Recommending aspirin for primary prevention in diabetic patients: what may we conclude from the data?

Authors:  Antonio Nicolucci
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

2.  Antiplatelet therapy for every diabetic person?

Authors:  Antonio Nicolucci; Eberhard Standl
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

3.  Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs.

Authors:  A Tufano; E Cimino; M N D Di Minno; P Ieranò; E Marrone; A Strazzullo; G Di Minno; A M Cerbone
Journal:  Int J Vasc Med       Date:  2011-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.